Clinical evaluation of Ayurvedic regimen (Virechana Karma followed by oral administration of Kankayana Vati, Kanchanara guggulu and Kumaryasava) in the management of Polycystic Ovarian Syndrome- A Randomized Controlled open label Clinical Trial

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年6月26日

试验速览

暂无简介。

•1.DIAGNOSED WITH PCOS as defined by Rotterdam revised criteria 2003 (2 out of 3 symptoms if present)
•a.Anovulation or Oligo-ovulation
•b.Hyperandrogenism- Clinical (acne, hirsutism, acanthosis nigricans). Or Biochemical: total testosterone >70ng/dl
•c.Polycystic ovary on USG ( >12 Follicles in an ovary each of 2-9mm in size) ovarian volume >10 cm3
•2.Willing and able to participate in the study

•1.Participants who want to conceive during this period or planning for pregnancy will be excluded.
•2.Organic lesions of reproductive tract like T.B, Carcinoma and Congenital deformities.
•3. Participants suffering from Hypertension, Diabetes Mellitus, Hepatic/Renal disease, Cushingâ??s syndrome, Cardiac diseases.
•4.A current or previous use of OC pills, Glucocorticoids, anti-androgens, Ovulation induction agents, anti-diabetic, anti-obesity drug or other hormonal drug recently to be excluded unless a washout period of 3 months.
•5.Pelvic inflammatory disease or Cervicitis Evidence of malignancy or cervical intra-epithelial neoplasia or cervical carcinoma.
•6.History of untreated sexually transmitted disease or known to be HIV positive.
•7.Pregnant / Lactating women.
•8.Participant who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
•9.H/o hypersensitivity to the trial drug or any of its ingredients.
•10.Currently participating in any other clinical trial or participated in past 6 months.
•11.Any other condition which the Principal Investigator thinks may jeopardize the study.
•Virechana Ayogy

发起方